Macclesfield, United Kingdom

Liselotte Ohberg

USPTO Granted Patents = 8 


Average Co-Inventor Count = 7.7

ph-index = 5

Forward Citations = 34(Granted Patents)


Location History:

  • Cheshire, GB (2015)
  • Macclesfield, GB (2014 - 2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Liselotte Ohberg: Innovator in Pharmaceutical Compounds

Introduction

Liselotte Ohberg is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BACE inhibitors. With a total of 8 patents to her name, her work is crucial in addressing various cognitive impairments and related disorders.

Latest Patents

Her latest patents focus on compounds and their use as BACE inhibitors. These inventions relate to therapeutic methods for the treatment and prevention of Aβ-related pathologies, including Down's syndrome and β-amyloid angiopathy. The compounds are designed to combat disorders associated with cognitive impairment, such as mild cognitive impairment (MCI), Alzheimer's disease, and other forms of dementia.

Career Highlights

Liselotte Ohberg is currently employed at AstraZeneca AB, where she continues to innovate in the pharmaceutical sector. Her research is pivotal in developing new treatments for neurodegenerative diseases, which affect millions worldwide.

Collaborations

Throughout her career, Liselotte has collaborated with notable colleagues, including Sofia Karlstrom and Peter Soderman. These partnerships have enhanced her research and contributed to the advancement of her inventions.

Conclusion

Liselotte Ohberg's work in developing BACE inhibitors represents a significant advancement in the treatment of cognitive disorders. Her contributions to the pharmaceutical industry are invaluable, and her ongoing research promises to improve the lives of many individuals affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…